Gaëlle spent 13 years in France and Canada developing animals models to investigate the therapeutic avenues of major Central Nervous System disorders, such as depression and Alzheimer’s disease, neuro-inflammation processes which relate to otic and hearing diseases. Aside from developing drugs for CNS disorders, she has a wide range of project management and business development competencies, and is the author of many scientific communications and publications, as well as receiving many scholarships and awards.